Skip to main content
Kane Biotech
Biofilms
Overview
Understanding Biofilms
coactiv+™
DispersinB
®
Glossary Of Terms
Commercialization Vehicles
Overview
Kane Wound Care & Surgical
Kane Dermatology
About
Overview
Our Team
Careers
Contact
Publications
Blog
Publications / Posters
News / Events
Investors
Overview
News / Events
Company Information
Financial Results
Stock Data
SEDAR
Corporate Governance
Press Releases
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investors
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Overview of Kane Wound Care
DermaKB OTC Shampoo Trials
Presentations
Management Team
Contacts
Financial Results
Stock Data
TSX-V:KNE
OTCQB:KNBIF
SEDAR
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
News / Events
Press Releases
IR Calendar
Email Alerts
All News
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Kane Biotech Commences Veterinary Clinic Testing of StrixNB(TM) Pet Oral Care Product
Sep 19, 2012
Kane Biotech Announces Changes to the Board of Directors
Sep 17, 2012
Kane Biotech Presents Innovation at 2012 Kansas City Animal Health Investment Forum
Aug 28, 2012
Kane Biotech Announces Grant of Options and Updates Investor Relations Agreement
Jul 9, 2012
Kane Biotech Announces Board Members
Jul 3, 2012
Kane Biotech Files PCT Patent on Bone Tissue Regeneration Technology
May 30, 2012
Kane Biotech Successfully Completes Pilot Animal Study on Pet Oral Care Product
May 15, 2012
Kane Biotech Develops New Pet Oral Care Product
May 1, 2012
Kane Biotech Successfully Completes Wound Gel for the United States Army
Apr 17, 2012
Kane Biotech Provides Corporate Update
Feb 22, 2012
1...
26
27
28
29
30
31
32
33
34
35
...39